{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T01:34:47Z","timestamp":1775093687922,"version":"3.50.1"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2016,7,9]],"date-time":"2016-07-09T00:00:00Z","timestamp":1468022400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Impulse Dynamics"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1007\/s10741-016-9571-6","type":"journal-article","created":{"date-parts":[[2016,7,9]],"date-time":"2016-07-09T01:55:08Z","timestamp":1468029308000},"page":"645-660","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":71,"title":["Cardiac contractility modulation: a novel approach for the treatment of heart failure"],"prefix":"10.1007","volume":"21","author":[{"given":"Freddy","family":"Abi-Samra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2814-7867","authenticated-orcid":false,"given":"David","family":"Gutterman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,7,9]]},"reference":[{"key":"9571_CR1","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1161\/CIR.0000000000000152","volume":"131","author":"D Mozaffarian","year":"2015","unstructured":"Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M et al (2015) Heart disease and stroke statistics\u20132015 update: a report from the American Heart Association. Circulation 131:e29\u2013e322","journal-title":"Circulation"},{"key":"9571_CR2","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1161\/HHF.0b013e318291329a","volume":"6","author":"PA Heidenreich","year":"2013","unstructured":"Heidenreich PA, Albert NM, Allen LA, Bluemke DA, Butler J, Fonarow GC et al (2013) Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circ Heart Fail 6:606\u2013619","journal-title":"Circ Heart Fail"},{"key":"9571_CR3","doi-asserted-by":"crossref","unstructured":"Liu L, Eisen HJ (2014) Epidemiology of heart failure and scope of the problem. Cardiol Clin 32:1\u20138, vii","DOI":"10.1016\/j.ccl.2013.09.009"},{"key":"9571_CR4","first-page":"269","volume":"106","author":"T Neumann","year":"2009","unstructured":"Neumann T, Biermann J, Erbel R, Neumann A, Wasem J, Ertl G et al (2009) Heart failure: the commonest reason for hospital admission in Germany: medical and economic perspectives. Dtsch Arztebl Int 106:269\u2013275","journal-title":"Dtsch Arztebl Int"},{"key":"9571_CR5","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1001\/jama.292.3.344","volume":"292","author":"VL Roger","year":"2004","unstructured":"Roger VL, Weston SA, Redfield MM, Hellermann-Homan JP, Killian J, Yawn BP et al (2004) Trends in heart failure incidence and survival in a community-based population. JAMA 292:344\u2013350","journal-title":"JAMA"},{"key":"9571_CR6","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1001\/jama.2011.1474","volume":"306","author":"J Chen","year":"2011","unstructured":"Chen J, Normand SL, Wang Y, Krumholz HM (2011) National and regional trends in heart failure hospitalization and mortality rates for Medicare beneficiaries, 1998\u20132008. JAMA 306:1669\u20131678","journal-title":"JAMA"},{"key":"9571_CR7","unstructured":"Pfuntner A, Wier LM, Stocks C. Most Frequent Conditions in U.S. Hospitals, 2011: Statistical Brief #162. Healthcare Cost and Utilization Project (HCUP) Statistical Briefs. Rockville (MD)2006"},{"key":"9571_CR8","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1161\/CIR.0b013e31829e8807","volume":"128","author":"CW Yancy","year":"2013","unstructured":"Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH et al (2013) 2013 ACCF\/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines. Circulation 128:1810\u20131852","journal-title":"Circulation"},{"key":"9571_CR9","doi-asserted-by":"crossref","first-page":"e240","DOI":"10.1161\/CIR.0b013e31829e8776","volume":"128","author":"M Writing Committee","year":"2013","unstructured":"Writing Committee M, Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr et al (2013) 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines. Circulation 128:e240\u2013e327","journal-title":"Circulation"},{"key":"9571_CR10","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1093\/eurheartj\/ehs105","volume":"33","author":"J Taylor","year":"2012","unstructured":"Taylor J (2012) The 2012 ESC Guidelines on Heart Failure. Eur Heart J 33:1703\u20131704","journal-title":"Eur Heart J"},{"key":"9571_CR11","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJM198606123142404","volume":"314","author":"JN Cohn","year":"1986","unstructured":"Cohn JN, Archibald DG, Ziesche S, Franciosa JA, Harston WE, Tristani FE et al (1986) Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study. N Engl J Med 314:1547\u20131552","journal-title":"N Engl J Med"},{"key":"9571_CR12","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1056\/NEJMoa042934","volume":"351","author":"AL Taylor","year":"2004","unstructured":"Taylor AL, Ziesche S, Yancy C, Carson P, D\u2019Agostino R Jr, Ferdinand K et al (2004) Combination of isosorbide dinitrate and hydralazine in blacks with heart failure. N Engl J Med 351:2049\u20132057","journal-title":"N Engl J Med"},{"key":"9571_CR13","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1136\/hrt.72.2_Suppl.S44","volume":"72","author":"EB Raftery","year":"1994","unstructured":"Raftery EB (1994) Haemodynamic effects of diuretics in heart failure. Br Heart J 72:S44\u2013S47","journal-title":"Br Heart J"},{"key":"9571_CR14","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1093\/eurheartj\/ehi176","volume":"26","author":"S Gupta","year":"2005","unstructured":"Gupta S, Neyses L (2005) Diuretic usage in heart failure: a continuing conundrum in 2005. Eur Heart J 26:644\u2013649","journal-title":"Eur Heart J"},{"key":"9571_CR15","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","volume":"371","author":"JJ McMurray","year":"2014","unstructured":"McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR et al (2014) Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med 371:993\u20131004","journal-title":"N Engl J Med"},{"key":"9571_CR16","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/eurjhf\/hft129","volume":"16","author":"D Dobre","year":"2014","unstructured":"Dobre D, Borer JS, Fox K, Swedberg K, Adams KF, Cleland JG et al (2014) Heart rate: a prognostic factor and therapeutic target in chronic heart failure. The distinct roles of drugs with heart rate-lowering properties. Eur J Heart Fail 16:76\u201385","journal-title":"Eur J Heart Fail"},{"key":"9571_CR17","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0140-6736(10)61198-1","volume":"376","author":"K Swedberg","year":"2010","unstructured":"Swedberg K, Komajda M, Bohm M, Borer JS, Ford I, Dubost-Brama A et al (2010) Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. Lancet 376:875\u2013885","journal-title":"Lancet"},{"key":"9571_CR18","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1093\/eurheartj\/eht150","volume":"34","author":"M Brignole","year":"2013","unstructured":"Brignole M, Auricchio A, Baron-Esquivias G, Bordachar P, Boriani G, Breithardt OA et al (2013) 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Eur Heart J 34:2281\u20132329","journal-title":"Eur Heart J"},{"key":"9571_CR19","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nrcardio.2013.60","volume":"10","author":"LE Rohde","year":"2013","unstructured":"Rohde LE, Bertoldi EG, Goldraich L, Polanczyk CA (2013) Cost-effectiveness of heart failure therapies. Nat Rev Cardiol 10:338\u2013354","journal-title":"Nat Rev Cardiol"},{"issue":"Suppl 2","key":"9571_CR20","doi-asserted-by":"crossref","first-page":"ii13-7","DOI":"10.1093\/europace\/eur081","volume":"13","author":"F Braunschweig","year":"2011","unstructured":"Braunschweig F, Cowie MR, Auricchio A (2011) What are the costs of heart failure? Europace 13(Suppl 2):ii13-7","journal-title":"Europace"},{"key":"9571_CR21","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa043399","volume":"352","author":"GH Bardy","year":"2005","unstructured":"Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R et al (2005) Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352:225\u2013237","journal-title":"N Engl J Med"},{"key":"9571_CR22","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1056\/NEJM199912163412503","volume":"341","author":"AE Buxton","year":"1999","unstructured":"Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G (1999) A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 341:1882\u20131890","journal-title":"N Engl J Med"},{"key":"9571_CR23","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1056\/NEJM199612263352601","volume":"335","author":"AJ Moss","year":"1996","unstructured":"Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H et al (1996) Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 335:1933\u20131940","journal-title":"N Engl J Med"},{"key":"9571_CR24","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1056\/NEJMoa050496","volume":"352","author":"JG Cleland","year":"2005","unstructured":"Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L et al (2005) The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 352:1539\u20131549","journal-title":"N Engl J Med"},{"key":"9571_CR25","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa1306687","volume":"369","author":"F Ruschitzka","year":"2013","unstructured":"Ruschitzka F, Abraham WT, Singh JP, Bax JJ, Borer JS, Brugada J et al (2013) Cardiac-resynchronization therapy in heart failure with a narrow QRS complex. N Engl J Med 369:1395\u20131405","journal-title":"N Engl J Med"},{"issue":"2","key":"9571_CR26","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/europace\/euu214","volume":"17","author":"RM Shah","year":"2014","unstructured":"Shah RM, Patel D, Molnar J, Ellenbogen KA, Koneru JN (2014) Cardiac-resynchronization therapy in patients with systolic heart failure and QRS interval \u2264130\u00a0ms: insights from a meta-analysis. Europace. 17(2):267\u2013273","journal-title":"Europace"},{"key":"9571_CR27","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1157\/13097924","volume":"60","author":"JM Garcia-Pinilla","year":"2007","unstructured":"Garcia-Pinilla JM, Jimenez-Navarro MF, Anguita-Sanchez M, Martinez-Martinez A, Torres-Calvo F, Investigadores del registro R (2007) How many patients admitted for heart failure are eligible for cardiac resynchronization therapy? Analysis of the Andalusian Heart Failure Registry (RAIC) study. Rev Esp Cardiol 60:38\u201344","journal-title":"Rev Esp Cardiol"},{"key":"9571_CR28","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1016\/j.jacc.2005.01.071","volume":"46","author":"A Kashani","year":"2005","unstructured":"Kashani A, Barold SS (2005) Significance of QRS complex duration in patients with heart failure. J Am Coll Cardiol 46:2183\u20132192","journal-title":"J Am Coll Cardiol"},{"key":"9571_CR29","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1093\/eurheartj\/ehi826","volume":"27","author":"NM Hawkins","year":"2006","unstructured":"Hawkins NM, Petrie MC, MacDonald MR, Hogg KJ, McMurray JJ (2006) Selecting patients for cardiac resynchronization therapy: electrical or mechanical dyssynchrony? Eur Heart J 27:1270\u20131281","journal-title":"Eur Heart J"},{"key":"9571_CR30","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/01.hco.0000198983.93755.99","volume":"21","author":"DH Birnie","year":"2006","unstructured":"Birnie DH, Tang AS (2006) The problem of non-response to cardiac resynchronization therapy. Curr Opin Cardiol 21:20\u201326","journal-title":"Curr Opin Cardiol"},{"key":"9571_CR31","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/s00059-015-4362-8","volume":"40","author":"T Kleemann","year":"2015","unstructured":"Kleemann T (2015) Cardiac contractility modulation : a new form of therapy for patients with heart failure and narrow QRS complex? Herz 40:945\u2013951","journal-title":"Herz"},{"key":"9571_CR32","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1007\/s00259-011-1977-8","volume":"39","author":"G Goliasch","year":"2011","unstructured":"Goliasch G, Khorsand A, Schutz M, Karanikas G, Khazen C, Sochor H et al (2011) The effect of device-based cardiac contractility modulation therapy on myocardial efficiency and oxidative metabolism in patients with heart failure. Eur J Nucl Med Mol Imaging 39:408\u2013415","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"9571_CR33","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.cardfail.2006.11.004","volume":"13","author":"C Butter","year":"2007","unstructured":"Butter C, Wellnhofer E, Schlegl M, Winbeck G, Fleck E, Sabbah HN (2007) Enhanced inotropic state of the failing left ventricle by cardiac contractility modulation electrical signals is not associated with increased myocardial oxygen consumption. J Card Fail 13:137\u2013142","journal-title":"J Card Fail"},{"key":"9571_CR34","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.cardfail.2011.05.006","volume":"17","author":"WT Abraham","year":"2011","unstructured":"Abraham WT, Nademanee K, Volosin K, Krueger S, Neelagaru S, Raval N et al (2011) Subgroup analysis of a randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failure. J Card Fail 17:710\u2013717","journal-title":"J Card Fail"},{"key":"9571_CR35","first-page":"140","volume":"26","author":"SS Srivatsa","year":"2014","unstructured":"Srivatsa SS (2014) Finding the sweet spot for non-apical RV pacing\u2014\u201dlove\u2019s labor\u2019s lost or much ado about nothing:\u201d a new angiographic technique to accomplish accurate physiological RV septal pacing in under 5 minutes from venous cannulation (or bust). J Invasive Cardiol 26:140\u2013147","journal-title":"J Invasive Cardiol"},{"key":"9571_CR36","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1023\/A:1009851107189","volume":"6","author":"D Burkhoff","year":"2001","unstructured":"Burkhoff D, Shemer I, Felzen B, Shimizu J, Mika Y, Dickstein M et al (2001) Electric currents applied during the refractory period can modulate cardiac contractility in vitro and in vivo. Heart Fail Rev 6:27\u201334","journal-title":"Heart Fail Rev"},{"key":"9571_CR37","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1054\/jcaf.2003.8","volume":"9","author":"H Morita","year":"2003","unstructured":"Morita H, Suzuki G, Haddad W, Mika Y, Tanhehco EJ, Sharov VG et al (2003) Cardiac contractility modulation with nonexcitatory electric signals improves left ventricular function in dogs with chronic heart failure. J Card Fail 9:69\u201375","journal-title":"J Card Fail"},{"issue":"329\u201337","key":"9571_CR38","first-page":"e1","volume":"161","author":"A Kadish","year":"2011","unstructured":"Kadish A, Nademanee K, Volosin K, Krueger S, Neelagaru S, Raval N et al (2011) A randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failure. Am Heart J 161(329\u201337):e1\u2013e2","journal-title":"Am Heart J"},{"key":"9571_CR39","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/eurheartj\/ehn020","volume":"29","author":"MM Borggrefe","year":"2008","unstructured":"Borggrefe MM, Lawo T, Butter C, Schmidinger H, Lunati M, Pieske B et al (2008) Randomized, double blind study of non-excitatory, cardiac contractility modulation electrical impulses for symptomatic heart failure. Eur Heart J 29:1019\u20131028","journal-title":"Eur Heart J"},{"key":"9571_CR40","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.ehj.2004.02.027","volume":"25","author":"G Stix","year":"2004","unstructured":"Stix G, Borggrefe M, Wolpert C, Hindricks G, Kottkamp H, Bocker D et al (2004) Chronic electrical stimulation during the absolute refractory period of the myocardium improves severe heart failure. Eur Heart J 25:650\u2013655","journal-title":"Eur Heart J"},{"key":"9571_CR41","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/nrcardio.2013.114","volume":"10","author":"AR Lyon","year":"2013","unstructured":"Lyon AR, Samara MA, Feldman DS (2013) Cardiac contractility modulation therapy in advanced systolic heart failure. Nat Rev Cardiol 10:584\u2013598","journal-title":"Nat Rev Cardiol"},{"key":"9571_CR42","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ejheart.2005.05.011","volume":"8","author":"CB Brunckhorst","year":"2006","unstructured":"Brunckhorst CB, Shemer I, Mika Y, Ben-Haim SA, Burkhoff D (2006) Cardiac contractility modulation by non-excitatory currents: studies in isolated cardiac muscle. Eur J Heart Fail 8:7\u201315","journal-title":"Eur J Heart Fail"},{"key":"9571_CR43","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ejheart.2003.11.001","volume":"6","author":"H Morita","year":"2004","unstructured":"Morita H, Suzuki G, Haddad W, Mika Y, Tanhehco EJ, Goldstein S et al (2004) Long-term effects of non-excitatory cardiac contractility modulation electric signals on the progression of heart failure in dogs. Eur J Heart Fail 6:145\u2013150","journal-title":"Eur J Heart Fail"},{"key":"9571_CR44","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1016\/j.jacc.2008.01.036","volume":"51","author":"C Butter","year":"2008","unstructured":"Butter C, Rastogi S, Minden HH, Meyhofer J, Burkhoff D, Sabbah HN (2008) Cardiac contractility modulation electrical signals improve myocardial gene expression in patients with heart failure. J Am Coll Cardiol 51:1784\u20131789","journal-title":"J Am Coll Cardiol"},{"key":"9571_CR45","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1016\/j.jacc.2006.10.082","volume":"49","author":"M Imai","year":"2007","unstructured":"Imai M, Rastogi S, Gupta RC, Mishra S, Sharov VG, Stanley WC et al (2007) Therapy with cardiac contractility modulation electrical signals improves left ventricular function and remodeling in dogs with chronic heart failure. J Am Coll Cardiol 49:2120\u20132128","journal-title":"J Am Coll Cardiol"},{"key":"9571_CR46","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.jelectrocard.2014.08.011","volume":"47","author":"S Roger","year":"2014","unstructured":"Roger S, Michels J, Heggemann F, Stach K, Rousso B, Borggrefe M et al (2014) Long term impact of cardiac contractility modulation on QRS duration. J Electrocardiol 47:936\u2013940","journal-title":"J Electrocardiol"},{"key":"9571_CR47","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S1053-2498(02)00431-X","volume":"21","author":"F Grigioni","year":"2002","unstructured":"Grigioni F, Carinci V, Boriani G, Bracchetti G, Potena L, Magnani G et al (2002) Accelerated QRS widening as an independent predictor of cardiac death or of the need for heart transplantation in patients with congestive heart failure. J Heart Lung Transplant 21:899\u2013902","journal-title":"J Heart Lung Transplant"},{"key":"9571_CR48","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1161\/CIR.0b013e31828124ad","volume":"127","author":"AS Go","year":"2013","unstructured":"Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB et al (2013) Heart disease and stroke statistics\u20132013 update: a report from the American Heart Association. Circulation 127:e6\u2013e245","journal-title":"Circulation"},{"key":"9571_CR49","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1378\/chest.122.2.528","volume":"122","author":"HJ Shenkman","year":"2002","unstructured":"Shenkman HJ, Pampati V, Khandelwal AK, McKinnon J, Nori D, Kaatz S et al (2002) Congestive heart failure and QRS duration: establishing prognosis study. Chest 122:528\u2013534","journal-title":"Chest"},{"key":"9571_CR50","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1056\/NEJM200103223441202","volume":"344","author":"S Cazeau","year":"2001","unstructured":"Cazeau S, Leclercq C, Lavergne T, Walker S, Varma C, Linde C et al (2001) Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 344:873\u2013880","journal-title":"N Engl J Med"},{"key":"9571_CR51","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1111\/j.1540-8159.2012.03449.x","volume":"35","author":"JS Kwong","year":"2012","unstructured":"Kwong JS, Sanderson JE, Yu CM (2012) Cardiac contractility modulation for heart failure: a meta-analysis of randomized controlled trials. Pacing Clin electrophysiol 35:1111\u20131118","journal-title":"Pacing Clin electrophysiol"},{"key":"9571_CR52","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.ijcard.2014.06.005","volume":"175","author":"F Giallauria","year":"2014","unstructured":"Giallauria F, Vigorito C, Piepoli MF, Stewart Coats AJ (2014) Effects of cardiac contractility modulation by non-excitatory electrical stimulation on exercise capacity and quality of life: an individual patient\u2019s data meta-analysis of randomized controlled trials. Int J Cardiol 175:352\u2013357","journal-title":"Int J Cardiol"},{"key":"9571_CR53","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1093\/europace\/eur153","volume":"13","author":"T Schau","year":"2011","unstructured":"Schau T, Seifert M, Meyhofer J, Neuss M, Butter C (2011) Long-term outcome of cardiac contractility modulation in patients with severe congestive heart failure. Europace 13:1436\u20131444","journal-title":"Europace"},{"key":"9571_CR54","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ijcard.2014.12.178","volume":"183","author":"J Kuschyk","year":"2015","unstructured":"Kuschyk J, Roeger S, Schneider R, Streitner F, Stach K, Rudic B et al (2015) Efficacy and survival in patients with cardiac contractility modulation: long-term single center experience in 81 patients. Int J Cardiol 183:76\u201381","journal-title":"Int J Cardiol"},{"key":"9571_CR55","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ijcard.2016.01.071","volume":"206","author":"M Liu","year":"2016","unstructured":"Liu M, Fang F, Luo XX, Shlomo BH, Burkhoff D, Chan JY et al (2016) Improvement of long-term survival by cardiac contractility modulation in heart failure patients: a case-control study. Int J Cardiol 206:122\u2013126","journal-title":"Int J Cardiol"},{"key":"9571_CR56","doi-asserted-by":"crossref","unstructured":"Kloppe A, Lawo T, Mijic D, Schiedat F, Muegge A, Lemke B (2016) Long-term survival with cardiac contractility modulation in patients with NYHA II or III. Int J Cardiol","DOI":"10.1016\/j.ijcard.2016.02.001"},{"key":"9571_CR57","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.cardfail.2014.09.011","volume":"21","author":"WT Abraham","year":"2015","unstructured":"Abraham WT, Lindenfeld J, Reddy VY, Hasenfuss G, Kuck KH, Boscardin J et al (2015) A randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation in patients with moderately reduced left ventricular ejection fraction and a narrow QRS duration: study rationale and design. J Card Fail 21:16\u201323","journal-title":"J Card Fail"},{"key":"9571_CR58","doi-asserted-by":"crossref","unstructured":"Kloppe A, Mijic D, Schiedat F, Bogossian H, Mugge A, Rousso B, et al. (2015) A randomized comparison of 5 versus 12 hours per day of cardiac contractility modulation treatment for heart failure patients: a preliminary report. Cardiol J","DOI":"10.5603\/CJ.a2015.0073"},{"key":"9571_CR59","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1093\/europace\/eun257","volume":"10","author":"H Nagele","year":"2008","unstructured":"Nagele H, Behrens S, Eisermann C (2008) Cardiac contractility modulation in non-responders to cardiac resynchronization therapy. Europace 10:1375\u20131380","journal-title":"Europace"},{"key":"9571_CR60","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.ijcard.2015.10.208","volume":"203","author":"C Tschope","year":"2016","unstructured":"Tschope C, Van Linthout S, Spillmann F, Klein O, Biewener S, Remppis A et al (2016) Cardiac contractility modulation signals improve exercise intolerance and maladaptive regulation of cardiac key proteins for systolic and diastolic function in HFpEF. Int J Cardiol 203:1061\u20131066","journal-title":"Int J Cardiol"},{"key":"9571_CR61","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1093\/europace\/euu050","volume":"16","author":"S Roger","year":"2014","unstructured":"Roger S, Schneider R, Rudic B, Liebe V, Stach K, Schimpf R et al (2014) Cardiac contractility modulation: first experience in heart failure patients with reduced ejection fraction and permanent atrial fibrillation. Europace 16:1205\u20131209","journal-title":"Europace"},{"key":"9571_CR62","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.cardfail.2010.01.007","volume":"16","author":"HR Bogner","year":"2010","unstructured":"Bogner HR, Miller SD, de Vries HF, Chhatre S, Jayadevappa R (2010) Assessment of cost and health resource utilization for elderly patients with heart failure and diabetes mellitus. J Card Fail 16:454\u2013460","journal-title":"J Card Fail"},{"key":"9571_CR63","doi-asserted-by":"crossref","first-page":"43","DOI":"10.17987\/icfj.v4i0.173","volume":"4","author":"N Maniadakis","year":"2015","unstructured":"Maniadakis N, Fragoulakis V, Mylonas C, Sharma R, Coats AJ (2015) Economic evaluation of cardiac contractility modulation (CCM) therapy with the optimizer IVs in the management of heart failure patients. Int Cardiovascular Forum J 4:43\u201352","journal-title":"Int Cardiovascular Forum J"},{"key":"9571_CR64","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/S0195-668X(03)00199-4","volume":"24","author":"SD Thackray","year":"2003","unstructured":"Thackray SD, Witte KK, Nikitin NP, Clark AL, Kaye GC, Cleland JG (2003) The prevalence of heart failure and asymptomatic left ventricular systolic dysfunction in a typical regional pacemaker population. Eur Heart J 24:1143\u20131152","journal-title":"Eur Heart J"},{"key":"9571_CR65","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/eurjhf\/hfs078","volume":"14","author":"M Borggrefe","year":"2012","unstructured":"Borggrefe M, Burkhoff D (2012) Clinical effects of cardiac contractility modulation (CCM) as a treatment for chronic heart failure. Eur J Heart Fail 14:703\u2013712","journal-title":"Eur J Heart Fail"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-016-9571-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10741-016-9571-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-016-9571-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,10]],"date-time":"2019-09-10T19:12:06Z","timestamp":1568142726000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10741-016-9571-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,9]]},"references-count":65,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["9571"],"URL":"https:\/\/doi.org\/10.1007\/s10741-016-9571-6","relation":{},"ISSN":["1382-4147","1573-7322"],"issn-type":[{"value":"1382-4147","type":"print"},{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,9]]}}}